SimBioSys
SimBioSys is a TechBio company focused on redefining precision medicine and revolutionizing patient care to defeat cancer. They leverage artificial intelligence, data science, and spatial biophysics to create digital twins of tumors. Their technology addresses tumor heterogeneity by analyzing the tumor in its entirety, moving beyond traditional biopsies or 2D pathology slides. Their cloud-based platform offers solutions across the continuum of patient care, including clinical applications like TumorSight Viz for surgical planning and research solutions like PhenoScope for biomarker discovery. The company was founded in 2017 with a vision to individualize cancer therapy and improve patient outcomes, and has grown to over 20 employees with multiple peer-reviewed publications and collaborations with leading institutions.
SimBioSys
SimBioSys is a TechBio company focused on redefining precision medicine and revolutionizing patient care to defeat cancer. They leverage artificial intelligence, data science, and spatial biophysics to create digital twins of tumors. Their technology addresses tumor heterogeneity by analyzing the tumor in its entirety, moving beyond traditional biopsies or 2D pathology slides. Their cloud-based platform offers solutions across the continuum of patient care, including clinical applications like TumorSight Viz for surgical planning and research solutions like PhenoScope for biomarker discovery. The company was founded in 2017 with a vision to individualize cancer therapy and improve patient outcomes, and has grown to over 20 employees with multiple peer-reviewed publications and collaborations with leading institutions.